Pipeline is solid, revenue is growing, cash is growing, and stoke indication could be a BLOCKBUSTER. This baby is cheap!!!!!Continuing to grow position.
I think the zanaflex patent issues are still weighing on the stock. Zanaflex was a very small piece of the operations to begin with, but I see how the estimates could be effected.